Impact of screening and treatment on racial and ethnic differences in health service use, cost, and mortality among advanced (T3 or greater) prostate cancer patients.

Authors

null

S. Bruce Malkowicz

Department of Urology, Hospital of the University of Pennsylvania,, Philadelphia, PA

S. Bruce Malkowicz , Sumedha Chhatre , Sanford Schwartz , Ravishankar Jayadevappa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 131)

DOI

10.1200/jco.2014.32.4_suppl.131

Abstract #

131

Poster Bd #

H8

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

Association between sociodemographic factors and diagnosis of advanced prostate cancer in early life.

Association between sociodemographic factors and diagnosis of advanced prostate cancer in early life.

First Author: Shayan Smani

Poster

2023 ASCO Annual Meeting

Talk, test, and take one click to curb prostate cancer mortality.

Talk, test, and take one click to curb prostate cancer mortality.

First Author: Sandhya Cautha

Poster

2023 ASCO Annual Meeting

Enzalutamide vs abiraterone in patients with prostate cancer with and without type 2 diabetes mellitus.

Enzalutamide vs abiraterone in patients with prostate cancer with and without type 2 diabetes mellitus.

First Author: Amy L Shaver

Poster

2023 ASCO Genitourinary Cancers Symposium

Correlation of age and the tumor transcriptomic profile in patients (pts) with advanced prostate cancer (PCa).

Correlation of age and the tumor transcriptomic profile in patients (pts) with advanced prostate cancer (PCa).

First Author: Kamal Kant Kant Sahu